Hiv-1 Infections
📧 Sign up to get email alerts when something new happens for Hiv-1 Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV [Phase 3]
A Phase 3 study providing continued access to darunavir/ritonavir for HIV-1 infected individuals from prior studies; completed with results …
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV [Phase 2]
A Phase 2 pediatric study update providing continued access to darunavir/ritonavir for children originally enrolled in ongoing Tibotec pedia…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: HIV PrEP Priming of Immune Effectors [Phase 4]
A Phase 4 clinical trial update exploring HIV PrEP priming of immune effectors.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Observational Data Analysis in EuroSIDA (MK-0518-058)
Observational data analysis update for an HIV-1 infection study (MK-0518-058) reported as completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults [Phase 2]
Phase 2 trial evaluating safety and effectiveness of raltegravir plus darunavir/ritonavir in treatment-naive HIV-1 infections; completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.